Breaking News

SAFC Licenses Cell Line Platform in Asia

Will be used to maximize MAb production and other r-proteins

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

SAFC Commercial, Sigma-Aldrich’s custom manufacturing services business unit, has won commercial sales and licensing contracts with two Asian biopharma companies for the purchase of CHOZN, its off-the-shelf cell line production platform.   The CHOZN Platform consists of the CHOZN GS-/- CHO cell line and an optimized set of cGMP-produced, chemically defined (CD) media and feeds designed specifically for the cell line to maximize the production of monoclonal antibodies and other r-proteins. Accord...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters